Products > IHC > Antibodies for immunohistochemistry

Antibodies for immunohistochemistry

Reach out to the antigen

In addition to the well-known own brand Zytomed Systems, the current program includes tried and tested reagents from Diagnostic Biosystems, BioCare Medical, Zeta Corporation among others. We are constantly testing new antibodies and detection systems to meet the specific requirements of the laboratories and scientific users in the best possible way. Most of the primary antibodies are available both as concentrates and as ready-to-use products.

Sorry, no results could be found for your request.
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Host Rabbit
Clone ZR333
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Tonsil
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Recombinant Human FOXP1 protein
Localization Nuclear
FOXP1 		ZR333 Z2639RT
Host Rabbit
Clone SP97
Format Concentrate
Method P
Pretreatment Citrate
Positive control Tonsil
Dilution 1:100
Isotype Rabbit IgG
Immunogen A synthetic peptide corresponding to C-terminus of human FoxP3 protein
Localization Nucleus
FOXP3 		SP97 506-3970
Host Rabbit
Clone SP97
Format Concentrate
Method P
Pretreatment Citrate
Positive control Tonsil
Dilution 1:100
Isotype Rabbit IgG
Immunogen A synthetic peptide corresponding to C-terminus of human FoxP3 protein
Localization Nucleus
FOXP3 		SP97 506-3972
Host Rabbit
Clone SP97
Format Concentrate
Method P
Pretreatment Citrate
Positive control Tonsil
Dilution 1:100
Isotype Rabbit IgG
Immunogen A synthetic peptide corresponding to C-terminus of human FoxP3 protein
Localization Nucleus
FOXP3 		SP97 506-3974
Host Mouse
Clone 86D
Format Concentrate
Method P
Pretreatment Citrate
Positive control Colon cancer, tonsil
Dilution 1:100
Isotype IgG1
Localization Nucleus
FOXP3 		86D ACI3197A
Host Mouse
Clone 86D
Format Concentrate
Method P
Pretreatment Citrate
Positive control Colon cancer, tonsil
Dilution 1:100
Isotype IgG1
Localization Nucleus
FOXP3 		86D ACI3197C
Host Mouse
Clone 236A/E7
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Colon cancer, melanoma
Dilution -
Isotype IgG1
Localization Nucleus
FOXP3 		236A/E7 API3164AA
Host Mouse
Clone 86D
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Colon cancer, tonsil
Dilution -
Isotype IgG1
Localization Nucleus
FOXP3 		86D API3197AA
Host Rabbit
Clone ZR246
Format Concentrate
Reactivity -
Method P
Positive control Pituitary
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Recombinant full-length hFSH beta sub-unit
Localization Cytoplasm
FSH 		ZR246 Z2721RL
Host Rabbit
Clone ZR246
Format Concentrate
Reactivity -
Method P
Positive control Pituitary
Dilution -
Isotype IgG
Immunogen Recombinant full-length hFSH beta sub-unit
Localization Cytoplasm
FSH 		ZR246 Z2721RP
Host Rabbit
Clone ZR246
Format Concentrate
Reactivity -
Method P
Positive control Pituitary
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Recombinant full-length hFSH beta sub-unit
Localization Cytoplasm
FSH 		ZR246 Z2721RS
Host Rabbit
Clone ZR246
Format Concentrate
Reactivity -
Method P
Positive control Pituitary
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Recombinant full-length hFSH beta sub-unit
Localization Cytoplasm
FSH 		ZR246 Z2721RT
Host Mouse
Clone BGN/F63/02
Format Purified
Method EL
Isotype Mouse IgG1
Immunogen Intact Follicle Stimulating Hormone
FSH (Follicle Stimulating Hormone) 		BGN/F63/02 606-0161
Host Mouse
Clone GAL3-3B8
Format Concentrate
Method P
Pretreatment Citrate
Positive control Papillary thyroid carcinoma
Dilution 1:100 - 1:200
Isotype IgG1 kappa
Localization Cytoplasm
Galectin-3 		GAL3-3B8 ACI3174A
Host Mouse
Clone GAL3-3B8
Format Concentrate
Method P
Pretreatment Citrate
Positive control Papillary thyroid carcinoma
Dilution 1:100 - 1:200
Isotype IgG1 kappa
Localization Cytoplasm
Galectin-3 		GAL3-3B8 ACI3174B
Host Mouse
Clone GAL3-3B8
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Papillary thyroid carcinoma
Isotype IgG1 kappa
Localization Cytoplasm
Galectin-3 		GAL3-3B8 API3174AA
Host Mouse
Clone H-5
Format Concentrate
Method P
Pretreatment Citrate
Positive control Colon carcinoma, papillary thyroid carcinoma
Dilution 1:50 - 1:100
Isotype IgG1
Localization Cytoplasm, nucleus
Galectin-3 		H-5 MOB541
Host Mouse
Clone H-5
Format Concentrate
Method P
Pretreatment Citrate
Positive control colon carcinoma, papillary thyroid carcinoma
Dilution 1:50 - 1:100
Isotype IgG1
Localization Cytoplasm, nucleus
Galectin-3 		H-5 MOB541-01
Host Mouse
Clone H-5
Format Concentrate
Method P
Pretreatment Citrate
Positive control Colon carcinoma, papillary thyroid carcinoma
Dilution 1:50 - 1:100
Isotype IgG1
Localization Cytoplasm, nucleus
Galectin-3 		H-5 MOB541-05
Host Mouse
Clone H-5
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Colon carcinoma, papillary thyroid carcinoms
Dilution -
Isotype IgG1
Localization Cytoplasm, nucleus
Galectin-3 		H-5 PDM541
Host Mouse
Clone H-5
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Colon carcinoma, papillary thyroid carcinoma
Dilution -
Isotype IgG1
Galectin-3 		H-5 PDM541-25
Host Monospecific Mouse
Clone ZM182
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Papillary or follicular thyroid carcinoma
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen A synthetic peptide from the C-terminus of human LGALS3 protein (aa 150-200)
Localization Cytoplasm
Galectin-3 		ZM182 Z2487ML
Host Monospecific Mouse
Clone ZM182
Format Ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Papillary or follicular thyroid carcinoma
Dilution -
Isotype IgG1 /κ
Immunogen A synthetic peptide from the C-terminus of human LGALS3 protein (aa 150-200)
Localization Cytoplasm
Galectin-3 		ZM182 Z2487MP
Host Monospecific Mouse
Clone ZM182
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Papillary or follicular thyroid carcinoma
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen A synthetic peptide from the C-terminus of human LGALS3 protein (aa 150-200)
Localization Cytoplasm
Galectin-3 		ZM182 Z2487MS
Host Monospecific Mouse
Clone ZM182
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Papillary or follicular thyroid carcinoma
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen A synthetic peptide from the C-terminus of human LGALS3 protein (aa 150-200)
Localization Cytoplasm
Galectin-3 		ZM182 Z2487MT
Host Rabbit
Clone polyclonal
Format Ready-to-use
Method F, P
Positive control Stomach
Dilution -
Isotype Rabbit IgG
Localization Cytoplasm
Gastrin 		polyclonal PDR027
Host Rabbit
Clone polyclonal
Format Concentrate
Method F, P
Positive control Stomach
Dilution 1:50 - 1:100
Isotype Rabbit IgG
Localization Cytoplasm
Gastrin 		polyclonal RP044
Host Rabbit
Clone polyclonal
Format Concentrate
Method F, P
Positive control Stomach
Dilution 1:50 - 1:100
Isotype Rabbit IgG
Localization Cytoplasm
Gastrin 		polyclonal RP044-01
Host Rabbit
Clone polyclonal
Format Concentrate
Method F, P
Positive control Stomach
Dilution 1:50 - 1:100
Isotype Rabbit IgG
Localization Cytoplasm
Gastrin 		polyclonal RP044-05
Host Mouse
Clone ZM359
Format Ready-to-use
Method F, P
Positive control Normal gastric mucosa
Dilution -
Isotype IgG1 /κ
Immunogen Recombinant full-length human GAST protein
Localization Cytoplasm
Gastrin 		ZM359 Z2735MP
Host Mouse
Clone L50-823
Format Concentrate
Reactivity -
Method P
Positive control Urothelial carcinoma.
Dilution 1:100
Isotype IgG1 /κ
Immunogen Conserved peptide between the GATA trans-activation and DNA-binding domain
Localization Nucleus
GATA-3 		L50-823 Z2227ML
Host Mouse
Clone L50-823
Format Ready-to-use
Reactivity -
Method P
Positive control Urothelial carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Conserved peptide between the GATA trans-activation and DNA-binding domain
Localization Nucleus
GATA-3 		L50-823 Z2227MP
Host Mouse
Clone L50-823
Format Concentrate
Reactivity -
Method P
Positive control Urothelial carcinoma.
Dilution 1:100
Isotype IgG1 /κ
Immunogen Conserved peptide between the GATA trans-activation and DNA-binding domain
Localization Nucleus
GATA-3 		L50-823 Z2227MS
Host Mouse
Clone L50-823
Format Concentrate
Reactivity -
Method P
Positive control Urothelial carcinoma.
Dilution 1:100
Isotype IgG1 /κ
Immunogen Conserved peptide between the GATA trans-activation and DNA-binding domain
Localization Nucleus
GATA-3 		L50-823 Z2227MT
Host Mouse
Clone L50-823
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Breast cancer
Dilution -
Isotype Mouse IgG1 kappa
Localization Nucleus
GATA3 		L50-823 ALI405G7
Host Mouse
Clone L50-823
Format Concentrate
Method P
Pretreatment Citrate
Positive control Breast cancer
Dilution 1:100 - 1:200
Isotype Mouse IgG1 kappa
Localization Nucleus
GATA3 		L50-823 CM405A
Host Mouse
Clone L50-823
Format Concentrate
Method P
Pretreatment Citrate
Positive control Breast cancer
Dilution 1:100 - 1:200
Isotype Mouse IgG1 kappa
Localization Nucleus
GATA3 		L50-823 CM405B
Host Mouse
Clone L50-823
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Breast cancer
Dilution -
Isotype Mouse IgG1 kappa
Localization Nucleus
GATA3 		L50-823 PM405AA
Host Mouse + Mouse
Clone L50-823 + BC21
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Bladder cancer
Dilution -
Isotype Mouse IgG1 kappa + Mouse IgG1 kappa
Localization Nuclear + Cytoplasmic/membrane
GATA3 + Uroplakin II 		L50-823 + BC21 API3173AA
Host Mouse
Clone DBM15.52
Format Concentrate
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution 1:50 - 1:100
Isotype IgG2a kappa
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 		DBM15.52 MOB526
Host Mouse
Clone DBM15.52
Format Concentrate
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution 1:50 - 1:100
Isotype IgG2a kappa
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 		DBM15.52 MOB526-01
Host Mouse
Clone DBM15.52
Format Concentrate
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution 1:50 - 1:100
Isotype IgG2a kappa
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 		DBM15.52 MOB526-05
Host Mouse
Clone DBM15.52
Format Ready-to-use
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution -
Isotype IgG2a kappa
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 		DBM15.52 PDM261
Host Mouse
Clone DBM15.52
Format Ready-to-use
Method P
Pretreatment EDTA
Positive control Breast carcinoma
Dilution -
Isotype IgG2a kappa
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 		DBM15.52 PDM261-25
Host Monospecific Mouse
Clone ZM23
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Skin and breast.
Dilution 1:100 - 1:200
Isotype IgG2b /κ
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 (Gross Cystic Disease Fluid Protein, BRST-2) 		ZM23 Z2345ML
Host Monospecific Mouse
Clone ZM23
Format Ready-to-use
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Skin and breast.
Dilution -
Isotype IgG2b /κ
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 (Gross Cystic Disease Fluid Protein, BRST-2) 		ZM23 Z2345MP
Host Monospecific Mouse
Clone ZM23
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Skin and breast.
Dilution 1:100 - 1:200
Isotype IgG2b /κ
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 (Gross Cystic Disease Fluid Protein, BRST-2) 		ZM23 Z2345MS
Host Monospecific Mouse
Clone ZM23
Format Concentrate
Reactivity -
Method P
Pretreatment Citrate or EDTA
Positive control Skin and breast.
Dilution 1:100 - 1:200
Isotype IgG2b /κ
Immunogen Recombinant human GCDFP-15 protein fragment (aa 41-146)
Localization Cytoplasm
GCDFP-15 (Gross Cystic Disease Fluid Protein, BRST-2) 		ZM23 Z2345MT
Host Mouse+Rabbit
Clone D6+31A5
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Breast
Dilution -
Isotype Mouse IgG2a+Rabbit IgG
Localization Cytoplasmic
GCDFP-15 + Mammaglobin 		D6+31A5 PM317DSAA
Host Mouse
Clone GA-5
Format Concentrate
Reactivity -
Method P
Positive control Brain or astrocytoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Native GFAP purified from pig spinal cord
Localization Cytoplasm
GFAP 		GA-5 Z2255ML
< Page 27 of 65 >
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Load more

Key to the method:

EL = ELISA; F = Frozen section IHC; FL = Flow Cytometry; IF = Immunfluoreszenz; IP = Immunoprecipitation; P = Paraffin section IHC; WB = Western Blot; u. a. = and others

Products

Topics

Learning videos

Downloads

Company

Distributors

Privacy Imprint
DE EN

Product availability

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Got it